Valutazione economica del trattamento con impianto intravitreale biodegradabile di desametasone di pazienti affetti da edema maculare secondario a occlusione della vena retinica, in Italia

Macular edema (ME) secondary to retinal vein occlusion (RVO) is an important cause of vision loss resulting in substantial morbidity in terms of reduced health-related quality of life and functioning. Until recently, no approved pharmacological treatment options were available.